Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 17/20 | 0.68 |
| ▸ | RAF1 | P04049 | 2/20 | 0.49 |
| ▸ | BRAF | P15056 | 2/20 | 0.49 |
| ▸ | CSF1R | P07333 | 1/20 | 0.49 |
| ▸ | SMO | Q99835 | 1/20 | 0.49 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.49 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.49 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.49 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7856914 | 0.93 | MAPK14 (0.70) | MAPK14 | |
| SCHEMBL6979521 | 0.92 | MAPK14 (0.58) | MAPK14RAF1BRAFCSF1RSMO | |
| SCHEMBL6976106 | 0.89 | MAPK14 (0.60) | MAPK14RAF1BRAFSMOMAPK13 | |
| SCHEMBL6476455 | 0.89 | OPRK1 (0.61) | MAPK14CSF1RSMO | |
| SCHEMBL6975779 | 0.86 | MAPK14 (0.58) | MAPK14RAF1BRAFSMOMAPK13 | |
| SCHEMBL6974083 | 0.86 | MAPK14 (0.59) | MAPK14RAF1BRAFSMOMAPK13 | |
| SCHEMBL6973786 | 0.85 | MAPK14 (0.57) | MAPK14RAF1BRAFSMOMAPK13 | |
| SCHEMBL6969088 | 0.85 | MAPK14 (0.61) | MAPK14SMOMAPK13HSPB1MAPK12 | |
| SCHEMBL7809447 | 0.84 | OPRK1 (0.56) | MAPK14CSF1RSMO | |
| SCHEMBL5897136 | 0.83 | MAPK14 (0.75) | MAPK14RAF1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1115707-B1 | BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2003-11-12 | — | — | EP | claimed |
| US-6455520-B1 | TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS | ASTRA ZENECA AB (SE) | 2002-09-24 | — | — | US | claimed |
| EP-1115707-B1 | BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS | ASTRAZENECA AB (SE) | 2003-11-12 | — | — | EP | disclosed |